This FTO-driven activation of proangiogenic CAFs significantly promotes tumor progression by fueling angiogenesis in conjunctival melanoma, thereby establishing FTO as a therapeutic target with translational potential for antiangiogenic strategies in oncology [241]. This evidence concerns the gene FTO and neoplasm.